Anwar Baydoun is an expert in Cardiovascular Pharmacology. An accomplished researcher in the field of cell signalling, applying his work to understanding physiological and pathophysiological mechanisms that may generate novel targets for drug development. He is most widely known for his work on nitric oxide and cationic amino acid transporters but also researches into the mechanisms that regulate the differentiation of stem cells into cardiomyocytes as well as those that regulate the process of vascular calcification in kidney and/or cardiovascular disease states.
Juliana Antonipillai is a lecturer in the College of Health & Biomedicine. She specialises in cancer and cardiovascular biology. Prior to joining Victoria University, Juliana was an academic researcher for 12 years at several medical research institutes and hospitals in Melbourne and the USA.
In the last five years her research has focused mainly on how LIMK regulates platelet function in humans and mice, and on the role of LIMK in cancer metastasis, using a variety of small molecule LIMK inhibitors. She demonstrated that these inhibitors inhibit the proliferation of human breast cancer cells in 2D and 3D cultures. She also contributed to a collaborative study showing the effect of a new LIMK inhibitor drug, Pyr1, on cancer cell growth in vitro and in mice.
Dept of Microbiology & Immunology
Jun-O Jin has provided valuables contributions in the area of immunology. He is currently working at Shanghai public health clinical center (SPHCC) affiliated to Fudan University in China. As a principal investigator, he is investigating host immune responses against bacterial infection and immune modulatory reagents for treatment of cancer and infectious diseases.
Recent his research interest is to develop novel cancer and infectious disease vaccine by fusion science. As a technological advance research using nano science, he suggests that Antigen and adjuvant delivery to dendritic cells in vivo could employ therapies that focus Antigen-specific immune responses; consequently the undesirable side-effects may be reduced or even eliminated. He believes that antigen and adjuvant delivery by nano career will be potentially useful for tumour and infectious disease vaccines.
Rozana Oliviera is a biology teacher in the Bahia state network, in the city of Salvador in Brazil. In 1997, I started a course in Biological Sciences at the Catholic University of Salvador. In 2001 I began my career in research as an intern in the Laboratory of Human Genetics and Medical Maternity Climrio de Oliveira. In 2006, I started a Master's degree in biotechnology and investigative medicine at Gonalo Muniz Research Center / Fiocruz, where I also completed a doctoral program (2008-2013). I won first prize in the Innovative Ideas prize (FAPESB 2015) in the category of Educational Innovations. I have experience in genetics, working mainly in the following subjects: occupational exposure, mutagenesis, exchanges between chromatid sisters, and recurrent abortion. I'm interested in the relationship between zika virus infection and the development of microcephaly. I have published in highly prestigious journals and presentations in conferences.